在急诊室接受治疗的败血症休克患者中,上腺素的发病时间和死亡率
German Devia Jaramillo1,2, Jose Wdroo Motta Hernández2, William Gerardo Donoso Zapata2
1Emergency Department, Hospital Universitario Fundación Santafé de Bogotá, Bogotá 111321, Colombia.
Journal of clinical medicine
|September 13, 2025
概括
在感染性休克患者的急诊室早期启动诺亚上腺素可显著降低住院死亡率. 这种关键的干预措施,当立即开始时,与性休克病例的更好的生存率有关.
科学领域:
- 紧急医疗 紧急医疗
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症和败血性休克是急诊室死亡的主要原因.
- 及时干预对于改善败血症休克生存率至关重要.
- 有限的研究存在于早期使用北上腺素,特别是在急诊室的环境中.
研究的目的:
- 调查成年败血性休克患者在急诊室开始使用诺亚上腺素的时间和住院死亡率之间的关联.
- 评估早期血管压缩剂使用对生存结果的影响.
主要方法:
- 在急诊室诊断出败血症休克的成年患者的回顾性队列研究.
- 对人口统计学,临床前变量和北上腺素启动时间的分析.
- 多变量分析来开发一个死亡率预测的nomogram.
主要成果:
- 研究人员发现,上腺素和生存时间之间存在显著的关联:幸存者的中位数为12分钟,非幸存者的中位数为104分钟 (p < 0.001).
- 增加北上腺素启动的时间与更高的死亡率比率有很强的相关性.
- 平均动脉压,动脉乳酸和肌水平也与死亡率有关.
结论:
- 在急诊室早期给予诺拉皮内林可能会降低因败血症休克而导致的住院死亡率.
- 这种干预似乎是安全的,不增加心律失常率.
- 需要进一步的研究来证实这些发现,并确定最佳的患者亚组.
相关概念视频
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
675
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
675
01:30Adrenergic Agonists: Therapeutic Uses
1.7K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.7K
01:28Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
01:30Acute Coronary Syndrome I: Introduction
828
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
828
01:18Drug Delivery: Enteral Route
1.6K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.6K
01:29Pulmonary Embolism I: Introduction
521
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
521